Multi-drug loaded vitamin E-TPGS nanoparticles for synergistic drug delivery to overcome drug resistance in tumor treatment

详细信息    查看全文

• 作者：Bo-Ya Liu ; Cong Wu ; Xiao-Yan He ; Ren-Xi Zhuo ; Si-Xue Cheng
• 关键词：Multi ; drug resistance ; Drug delivery ; Paclitaxel ; Tariquidar ; TPGS
• 刊名：Chinese Science Bulletin
• 出版年：2016
• 出版时间：April 2016
• 年：2016
• 卷：61
• 期：7
• 页码：552-560
• 全文大小：852 KB
• 参考文献：1.Creixell M, Peppas NA (2012) Co-delivery of siRNA and therapeutic agents using nanocarriers to overcome cancer resistance. Nano Today 7:367–379CrossRef
  2.Dean M, Rzhetsky A, Allikmets R (2001) The human ATP-binding cassette (ABC) transporter superfamily. Genome Res 11:1156–1166CrossRef
  3.Wang S, Qiu J, Shi Z et al (2015) Nanoscale drug delivery for taxanes based on the mechanism of multidrug resistance of cancer. Biotechnol Adv 33:224–241CrossRef
  4.Kurdziel KA, Kiesewetter DO, Carson RE et al (2003) Biodistribution, radiation dose estimates, and in vivo P-gp modulation studies of 18F-paclitaxel in nonhuman primates. J Nucl Med 44:1330–1339
  5.Loo TW, Clarke DM (2014) Tariquidar inhibits P-glycoprotein drug efflux but activates ATPase activity by blocking transition to an open conformation. Biochem Pharmacol 92:558–566CrossRef
  6.Sun Y, Chen J, Kumar P et al (2013) Reversal of MRP7 (ABCC10)-mediated multidrug resistance by tariquidar. PLoS One 8:e55576CrossRef
  7.Tang J, Fu Q, Wang Y et al (2013) Vitamin E reverses multidrug resistance in vitro and in vivo. Cancer Lett 336:149–157CrossRef
  8.Gao L, Liu G, Kang J et al (2013) Paclitaxel nanosuspensions coated with P-gp inhibitory surfactants: I. Acute toxicity and pharmacokinetics studies. Colloid Surf B Biointerfaces 111:277–281CrossRef
  9.Gao L, Liu G, Ma J et al (2014) Paclitaxel nanosuspension coated with P-gp inhibitory surfactants: II. Ability to reverse the drug-resistance of H460 human lung cancer cells. Colloid Surf B Biointerfaces 117:122–127CrossRef
  10.Shi C, Zhang Z, Wang F et al (2015) Docetaxel-loaded PEO–PPO–PCL/TPGS mixed micelles for overcoming multidrug resistance and enhancing antitumor efficacy. J Mater Chem B 3:4259–4271CrossRef
  11.Neophytou CM, Constantinou C, Papageorgis P et al (2014) D-alpha-tocopheryl polyethylene glycol succinate (TPGS) induces cell cycle arrest and apoptosis selectively in Survivin-overexpressing breast cancer cells. Biochem Pharmacol 89:31–42CrossRef
  12.Fan Z, Chen C, Pang X et al (2015) Adding vitamin E-TPGS to the formulation of Genexol-PM: specially mixed micelles improve drug-loading ability and cytotoxicity against multidrug resistant tumors significantly. PLoS One 10:e0120129CrossRef
  13.Bernabeu E, Helguera G, Legaspi MJ et al (2014) Paclitaxel-loaded PCL-TPGS nanoparticles: in vitro and in vivo performance compared with Abraxane(R). Colloid Surf B Biointerfaces 113:43–50CrossRef
  14.Sun Y, Yu B, Wang G et al (2013) Enhanced antitumor efficacy of vitamin E TPGS-emulsified PLGA nanoparticles for delivery of paclitaxel. Colloid Surf B Biointerfaces 123:716–723CrossRef
  15.Wang D, Tang J, Wang YJ et al (2013) Multifunctional nanoparticles based on a single-molecule modification for the treatment of drug resistant cancer. Mol Pharm 10:1465–1469CrossRef
  16.Mi Y, Liu Y, Feng SS (2011) Formulation of Docetaxel by folic acid-conjugated d-alpha-tocopheryl polyethylene glycol succinate 2000 (Vitamin E TPGS(2 k)) micelles for targeted and synergistic chemotherapy. Biomaterials 32:4058–4066CrossRef
  17.Muthu MS, Kulkarni SA, Raju A et al (2012) Theranostic liposomes of TPGS coating for targeted co-delivery of docetaxel and quantum dots. Biomaterials 33:3494–3501CrossRef
  18.Zhang Y, Huang Y, Zhao W et al (2014) Fmoc-conjugated PEG-vitamin E2 micelles for tumor-targeted delivery of paclitaxel: enhanced drug-carrier interaction and loading capacity. AAPS J 16:1282–1291CrossRef
  19.Qiu L, Qiao M, Chen Q et al (2014) Enhanced effect of pH-sensitive mixed copolymer micelles for overcoming multidrug resistance of doxorubicin. Biomaterials 35:9877–9887CrossRef
  20.Kutty RV, Feng SS (2013) Cetuximab conjugated vitamin E TPGS micelles for targeted delivery of docetaxel for treatment of triple negative breast cancers. Biomaterials 34:10160–10171CrossRef
  21.Wu Y, Chu Q, Tan S et al (2015) D-alpha-tocopherol polyethylene glycol succinate-based derivative nanoparticles as a novel carrier for paclitaxel delivery. Int J Nanomedicine 10:5219–5235
  22.Ma Y, Liu D, Wang D et al (2014) Combinational delivery of hydrophobic and hydrophilic anticancer drugs in single nanoemulsions to treat MDR in cancer. Mol Pharm 11:2623–2630CrossRef
  23.Zhao J, Feng SS (2014) Effects of PEG tethering chain length of vitamin E TPGS with a Herceptin-functionalized nanoparticle formulation for targeted delivery of anticancer drugs. Biomaterials 35:3340–3347CrossRef
  24.Lu J, Huang Y, Zhao W et al (2013) Design and characterization of PEG-derivatized vitamin E as a nanomicellar formulation for delivery of paclitaxel. Mol Pharm 10:2880–2890CrossRef
  25.Gao Z, Zhang L, Sun Y (2012) Nanotechnology applied to overcome tumor drug resistance. J Control Release 162:45–55CrossRef
  26.Patel NR, Rathi A, Mongayt D et al (2011) Reversal of multidrug resistance by co-delivery of tariquidar (XR9576) and paclitaxel using long-circulating liposomes. Int J Pharm 416:296–299CrossRef
  27.Yu DH, Liu YR, Luan X et al (2015) IF7-Conjugated nanoparticles target annexin 1 of tumor vasculature against P-gp mediated multidrug resistance. Bioconjug Chem 26:1702–1712CrossRef
  28.Bai F, Wang C, Lu Q et al (2013) Nanoparticle-mediated drug delivery to tumor neovasculature to combat P-gp expressing multidrug resistant cancer. Biomaterials 34:6163–6174CrossRef
  29.Gong MQ, Wu JL, Chen B et al (2015) Self-assembled polymer/inorganic hybrid nanovesicles for multiple drug delivery to overcome drug resistance in cancer chemotherapy. Langmuir 31:5115–5122CrossRef
  30.Shen J, Yin Q, Chen L et al (2012) Co-delivery of paclitaxel and survivin shRNA by pluronic P85-PEI/TPGS complex nanoparticles to overcome drug resistance in lung cancer. Biomaterials 33:8613–8624CrossRef
  31.Du AW, Lu H, Stenzel MH (2015) Core-cross-linking accelerates antitumor activities of paclitaxel-conjugate micelles to prostate multicellular tumor spheroids: a comparison of 2D and 3D models. Biomacromolecules 16:1470–1479CrossRef
  32.Lv W, Cheng L, Li B (2015) Development and evaluation of a novel TPGS-mediated paclitaxel-loaded PLGA-mPEG nanoparticle for the treatment of ovarian cancer. Chem Pharm Bull 63:68–74CrossRef
  33.Liu Y, Huang L, Liu F (2010) Paclitaxel nanocrystals for overcoming multidrug resistance in cancer. Mol Pharm 7:863–869CrossRef
  34.Mannino MH, Zhu Z, Xiao H et al (2015) The paradoxical role of IL-10 in immunity and cancer. Cancer Lett 367:103–107CrossRef
  35.Li C, Li H, Jiang K et al (2014) TLR4 signaling pathway in mouse Lewis lung cancer cells promotes the expression ofTGF-β1 and IL-10 and tumor cells migration. Biomed Mater Eng 24:869–875
  36.Sato T, Terai M, Tamura Y et al (2011) Interleukin 10 in the tumor microenvironment: a target for anticancer immunotherapy. Immunol Res 51:170–182CrossRef
  37.Javeed A, Ashraf M, Riaz A et al (2009) Paclitaxel and immune system. Eur J Pharm Sci 38:283–290CrossRef
  38.Chou TC (2006) Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev 58:621–681CrossRef
  
• 作者单位：Bo-Ya Liu (1)
  Cong Wu (1)
  Xiao-Yan He (1)
  Ren-Xi Zhuo (1)
  Si-Xue Cheng (1)
  
  1. Key Laboratory of Biomedical Polymers of Ministry of Education, Department of Chemistry, Wuhan University, Wuhan, 430072, China
  
• 刊物主题：Science, general; Life Sciences, general; Physics, general; Chemistry/Food Science, general; Earth Sciences, general; Engineering, general;
• 出版者：Springer Berlin Heidelberg
• ISSN：1861-9541

文摘

A facile self-assembly strategy to fabricate vitamin E-tocopheryl polyethylene glycol succinate (TPGS) based nanoparticles with a high drug loading level for co-delivery of multiple drugs was developed. To overcome multi-drug resistance, a chemotherapeutic agent (paclitaxel, PTX) and a drug resistance inhibitor (tariquidar, TQR) were co-loaded in the vitamin E-TPGS based nanoparticle to obtain TPGS/PTX/TQR nanoparticles. The sizes of mono-drug loaded TPGS/PTX nanoparticles and dual-drug loaded TPGS/PTX/TQR nanoparticles were below 150 nm with relatively narrow size distributions. The efficiencies of the drug delivery systems on tumor cells inhibition and reversal of drug resistance were evaluated in drug resistant cancer cells (MCF-7/ADR) as compared with nonresistant cells (HeLa). Due to the effective inhibition of the P-gp efflux by TQR, the dual-drug loaded nanoparticles exhibited significantly improved tumor cell inhibitory efficiency. To study the immunostimulatory effect, the effect of the drug delivery system on the production of IL-10, a cytokine related to tumor development, in the drug resistant cells was determined. After the treatment by the drug delivery systems, the concentration of IL-10 in the cell supernatant decreased. The multi-drug loaded vitamin E-TPGS nanoparticles for synergistic drug delivery have promising applications in reversal of drug resistance in tumor treatments.